Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.
Submissions from 2022
12-1-2022 330. BioFire ® FilmArray® Pneumonia Panel (PN) Results Compared to Standard Microbiologic Testing and Clinical Adjudication in Adults Hospitalized with Respiratory Illness, Ann R. Falsey, Rochester Regional Health, Angela R. Branche, University of Rochester, Maria A. Formica, Rochester Regional Health, et al.
11-10-2022 It’s Probably Just a Phage: Novel Treatment Strategies in Multi-Drug Resistant Infections, Alexandra Yamshchikov, Rochester Regional Health and Scott C. Feitell, Rochester Regional Health
11-1-2022 Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults, Angela R. Branche, Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, New York, USA., Lisa Saiman, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA., Edward E. Walsh, Rochester Regional Health, et al.
11-2022 Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial, Wesley H. Self, Vanderbilt University Medical Center; Allison P. Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee; and Maryrose Laguio-Vila, Rochester Regional Health
9-15-2022 Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months, Magdalena E Sobieszczyk, Columbia University Irving Medical Center, New York, New York, Jill Maaske, AstraZeneca, Gaithersburg, Maryland, Ann R. Falsey, Rochester Regional Health, et al.
9-8-2022 High Consequence Pathogens and HAI* (Healthcare Associated Infection) Priorities: Infectious Disease & Infectious Control Updates for 2022-2023, Emil P. Lesho, Rochester Regional Health
8-30-2022 A Simple Walk in the Park...Or is it? Lyme Disease, Michael Mancenido, Rochester Regional Health
7-19-2022 Monkeypox, Anja Bottler, Rochester Regional Health
6-17-2022 Rates of Medically Attended RSV among US Adults: A Systematic Review and Meta-Analysis, John M. McLaughlin, Pfizer Vaccines, Collegeville, PA, USA, Farid Khan, Pfizer Vaccines, Collegeville, PA, USA, Elizabeth Begier, Pfizer Vaccines, Collegeville, PA, USA, et al.
6-15-2022 Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine, Ann R. Falsey, Rochester Regional Health; Edward E. Walsh, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, 19426 USA.
5-15-2022 Go V.I.R.A.L.: Social Media Engagement Strategies in Infectious Diseases, Bradley J. Langford, Public Health Ontario, Toronto, Ontario, Canada., Maryrose Laguio-Vila, Rochester Regional Health, Timothy P. Gauthier, Baptist Health South Florida Clinical Pharmacy Enterprise, Miami, Florida, USA., et al.
4-15-2022 A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine, Edward E. Walsh, Rochester Regional Health; Ann R. Falsey, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
3-24-2022 Antimicrobial Stewardship Opportunities in Hospitalized Patients with Febrile Neutropenia, Carlos Portales Castillo, Rochester Regional Health and Maryrose R. Laguio-Vila, Rochester Regional Health
3-15-2022 Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020, Angela R. Branche, University of Rochester; Edward E. Walsh, Rochester Regional Health; and Ann R. Falsey, Rochester Regional Health
3-1-2022 Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York, Emil Lesho, Rochester Regional Health, Brendan Corey, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, Francois Lebreton, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, et al.
1-22-2022 Effectiveness of various cleaning strategies in acute and long-term care facilities during novel corona virus 2019 disease pandemic-related staff shortages, Emil Lesho, Rochester Regional Health, Donna Newhart, Rochester Regional Health, Lisa Reno, Rochester Regional Health, et al.
1-18-2022 COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
1-6-2022 COVID, Emil P. Lesho, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health
1-2022 Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire, Ann R. Falsey, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Richard H. Osborne, Department of Health and Medical Sciences, Swinburne University of Technology, Melbourne, Victoria, Australia., et al.
1-1-2022 Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019, Yoonyoung Choi, Merck & Co., Inc., Alexandra Hill-Ricciuti, Columbia University Irving Medical Center, Angela R. Branche, University of Rochester, et al.
Submissions from 2021
12-28-2021 A systems genomics approach uncovers molecular associates of RSV severity, Matthew N. McCall, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., Chin-Yi Chu, Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, University of Rochester Medical Center, Rochester New York, United States of America., Lu Wang, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., et al.
12-16-2021 Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine, Ann R. Falsey, Rochester Regional Health, Magdalena E. Sobieszczyk, Ian Hirsch, et al.
12-10-2021 A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development, Francois Lebreton, Walter Reed Army Institute of Research, Erik Snesrud, Walter Reed Army Institute of Research, Mary Hinkle, Rochester Regional Health, et al.
11-12-2021 Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells, Shuya Kyu, Emory University School of Medicine, Richard P. Ramonell, Emory University School of Medicine, Merin Kuruvilla, Emory University School of Medicine, et al.
11-1-2021 Pneumonia, Sinusitis, Influenza and Other Respiratory Illnesses in Acute Otitis Media-Prone Children, Michael E. Pichichero, Rochester Regional Health; Timothy J. Chapman, Rochester Regional Health; and Peter Bajorski, Rochester Institute of Technology